to compare the effects of heparin thrombolytic agents in pulmonary thromboembolic disease , we randomly assigned 40 patients with pulmonary emboli but without other clinical cardiopulmonary disease either to heparin followed by oral anticoagulants ( 21 patients ) or to urokinse or streptokinase followed by heparin and then by oral anticoagulants ( 19 patients ) .
C0034065
pulmonary emboli
C0038418
streptokinase